STAT3 signaling within the tumor microenvironment was recently elucidated to induce a protumor cytokine, IL-23, while inhibiting a central antitumor cytokine, IL-12, thereby shifting the balance of tumor immunity toward tumorigenesis (Figure 3) [12, 68]. This evidence concerns the gene IL23A and neoplasm.